- Title
- Hypoxia—implications for pharmaceutical developments
- Creators
- Lucas DONOVAN - Case Western Reserve University School of Medicine, Cleveland, OH, United StatesScott M WELFORD - Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, OH, United StatesJohn HAAGA - Case Western Reserve University School of Medicine, Cleveland, OH, United StatesJoseph LAMANNA - Case Western Reserve University School of Medicine, Cleveland, OH, United StatesKingman P STROHL - Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, United States
- Publication Details
- Sleep & breathing, Vol.14(4), pp.291-298
- Publisher
- Springer
- Academic Unit
- Miller School of Medicine; UMMG Dept of Radiation Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 20625934
- PMCID
- PMC3236526
- Record Identifier
- 991031598576802976
Journal article
Hypoxia—implications for pharmaceutical developments
Sleep & breathing, Vol.14(4), pp.291-298
2010
PMCID: PMC3236526
PMID: 20625934
Metrics
8 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.102 Stem Cell Research
- 1.102.996 HIF-1 Alpha
- Web Of Science research areas
- Clinical Neurology
- Respiratory System
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites